Jane De Lartigue, PhD

Article

Emerging biosimilars market presents opportunities and challenges

Author:

Jane De Lartigue, PhD

Publish date: December 6, 2018

• Read More

Article

Paradigm-changing osimertinib approval in front-line for advanced NSCLC

Author:

Jane De Lartigue, PhD

Publish date: December 6, 2018

• Read More

Article

BRAF-MEK inhibitor combo approved for adjuvant melanoma therapy

Author:

Jane De Lartigue, PhD

Publish date: December 6, 2018

• Read More

Article

Immunotherapy may hold the key to defeating virally associated cancers

Author:

Jane De Lartigue, PhD

Publish date: November 25, 2018

• Read More

Article

Game changers in pediatric cancer

Author:

Jane De Lartigue, PhD

Publish date: October 31, 2018

• Read More

Article

Addressing the rarity and complexities of sarcomas

Author:

Jane De Lartigue, PhD

Publish date: August 26, 2018

 

 

• Read More

Article

Tumor heterogeneity: a central foe in the war on cancer

Author:

Jane De Lartigue, PhD

Publish date: June 21, 2018

• Read More

Article

Expanding treatment options for diverse neuroendocrine tumors

Author:

Jane De Lartigue, PhD

Publish date: December 15, 2017

• Read More

Article

Hallmark tumor metabolism becomes a validated therapeutic target

Author:

Jane De Lartigue, PhD

Publish date: December 10, 2017

• Read More

Article

Targeted therapies forge ahead in multiple breast cancer subtypes

Author:

Jane De Lartigue, PhD

Publish date: December 1, 2017

• Read More

Article

Pancreatic cancer: a therapeutic challenge yet to be met

Author:

Jane De Lartigue, PhD

Publish date: December 22, 2016

• Read More

Article

Slow and steady progress in managing gynecologic cancer

Author:

Jane De Lartigue, PhD

Publish date: August 24, 2016

• Read More